{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:23Z","timestamp":1790916803004,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":180,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101309","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:54:24Z","timestamp":1783727664000},"page":"101309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PPAR\u03b3 activation sensitizes MSS gastrointestinal cancer cells to PD1 blockage"],"prefix":"10.1016","volume":"48","author":[{"given":"Juliane","family":"Reichling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gutting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Sticht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias P.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-5697","authenticated-orcid":false,"given":"Elke","family":"Burgermeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101309_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102716","article-title":"Updated cancer burden in oldest old: a population-based study using 2022 Globocan estimates","volume":"95","author":"Shah","year":"2025","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101309_bib0002","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/apt.18435","article-title":"Risk-adapted starting ages of colorectal cancer screening for people with diabetes or metabolic syndrome","volume":"61","author":"Seum","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41577-023-00973-8","article-title":"Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations","volume":"24","author":"Butterfield","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101309_bib0004","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0005","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat. Genet."},{"issue":"7517","key":"10.1016\/j.ctarc.2026.101309_bib0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101309_bib0007","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.trecan.2024.06.007","article-title":"Transcriptomic subtyping of gastrointestinal malignancies","volume":"10","author":"de Back","year":"2024","journal-title":"Trends. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0008","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","article-title":"Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours","volume":"24","author":"Holder","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101309_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007235","article-title":"Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer","volume":"11","author":"Akce","year":"2023","journal-title":"J. ImmunOther Cancer"},{"issue":"675","key":"10.1016\/j.ctarc.2026.101309_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0021","article-title":"Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer","volume":"14","author":"Tanaka","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2748","article-title":"Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells","volume":"10","author":"Glass","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101309_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1906500","article-title":"PPARgamma induces PD-L1 expression in MSS+ colorectal cancer cells","volume":"10","author":"Gutting","year":"2021","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0013","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1152\/ajpendo.00346.2023","article-title":"Thiazolidinedione enhances the efficacy of anti-PD-1 monoclonal antibody in murine melanoma","volume":"326","author":"Zhang","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0014","doi-asserted-by":"crossref","first-page":"01514","DOI":"10.1128\/mBio.01514-17","article-title":"Role of granulocyte-macrophage colony-stimulating factor production by T cells during mycobacterium tuberculosis infection","volume":"8","author":"Rothchild","year":"2017","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101309_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J. ImmunOther Cancer"},{"issue":"14","key":"10.1016\/j.ctarc.2026.101309_bib0016","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4093\/dmj.2023.0072","article-title":"Immune-checkpoint inhibitors-induced type 1 diabetes mellitus: from its molecular mechanisms to clinical practice","volume":"47","author":"Cho","year":"2023","journal-title":"Diabetes. Metab. J."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1423168","article-title":"PPARgamma-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice","volume":"7","author":"Gutting","year":"2018","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0019","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101309_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41419-023-06371-1","article-title":"Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARgamma","volume":"15","author":"Yu","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"D1","key":"10.1016\/j.ctarc.2026.101309_bib0021","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","article-title":"OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer","volume":"50","author":"Tang","year":"2022","journal-title":"Nucleic. Acids. Res."},{"issue":"W1","key":"10.1016\/j.ctarc.2026.101309_bib0022","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkab314","article-title":"Mol* viewer: modern web app for 3D visualization and analysis of large biomolecular structures","volume":"49","author":"Sehnal","year":"2021","journal-title":"Nucleic. Acids. Res."},{"issue":"Database issue","key":"10.1016\/j.ctarc.2026.101309_bib0023","doi-asserted-by":"crossref","first-page":"D261","DOI":"10.1093\/nar\/gkr1122","article-title":"PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse","volume":"40","author":"Hornbeck","year":"2012","journal-title":"Nucleic. Acids. Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101309_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00223890802634175","article-title":"The analysis of count data: a gentle introduction to poisson regression and its alternatives","volume":"91","author":"Coxe","year":"2009","journal-title":"J. Pers. Assess."},{"issue":"51","key":"10.1016\/j.ctarc.2026.101309_bib0025","doi-asserted-by":"crossref","first-page":"19600","DOI":"10.1074\/jbc.RA118.003280","article-title":"A dynamic transcriptomic atlas of cytokine-induced killer cells","volume":"293","author":"Meng","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101309_bib0026","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3109\/10428190309178764","article-title":"Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia","volume":"44","author":"Linn","year":"2003","journal-title":"Leuk. Lymphoma"},{"issue":"26","key":"10.1016\/j.ctarc.2026.101309_bib0027","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0028","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.yjmcc.2009.01.011","article-title":"PPARgamma enhances IFNgamma-mediated transcription and rescues the TGFbeta antagonism by stimulating CIITA in vascular smooth muscle cells","volume":"46","author":"Kong","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0029","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1091\/mbc.E15-07-0521","article-title":"Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation","volume":"27","author":"Smorodinsky-Atias","year":"2016","journal-title":"Mol. Biol. Cell"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101309_bib0030","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/1873-3468.13600","article-title":"Ciliogenesis associated kinase 1: targets and functions in various organ systems","volume":"593","author":"Fu","year":"2019","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101309_bib0031","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrm2063","article-title":"Membrane-protein topology","volume":"7","author":"von Heijne","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0032","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2014.06.048","article-title":"A secreted tyrosine kinase acts in the extracellular environment","volume":"158","author":"Bordoli","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101309_bib0033","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2767-9764.CRC-24-0082","article-title":"First-in-human Phase I trial of TPST-1120, an inhibitor of PPARalpha, as monotherapy or in combination with Nivolumab, in patients with advanced solid tumors","volume":"4","author":"Yarchoan","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101309_bib0034","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gutjnl-2022-328364","article-title":"Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma","volume":"72","author":"Xiong","year":"2023","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101309_bib0035","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcb.30437","article-title":"PPARgamma agonist inhibits c-Myc-mediated colorectal cancer tumor immune escape","volume":"124","author":"Xu","year":"2023","journal-title":"J. Cell Biochem."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0036","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1111\/cas.15818","article-title":"PPARgamma inhibited tumor immune escape by inducing PD-L1 autophagic degradation","volume":"114","author":"Gou","year":"2023","journal-title":"Cancer Sci."},{"issue":"15","key":"10.1016\/j.ctarc.2026.101309_bib0037","article-title":"A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes","volume":"100","author":"Nyambuya","year":"2021","journal-title":"Med. (Baltim.)"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0038","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.metabol.2012.12.005","article-title":"Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases","volume":"62","author":"Shi","year":"2013","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0039","first-page":"1","article-title":"Programmed death-Ligand 1 (PD-L1) expression is induced by insulin in pancreatic ductal adenocarcinoma cells pointing to its role in Immune checkpoint control","volume":"9","author":"Heckl","year":"2021","journal-title":"Med. Sci. (Basel)"},{"key":"10.1016\/j.ctarc.2026.101309_bib0040","article-title":"Diabetes mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung cancer-A matched case-control study","volume":"23","author":"Febres-Aldana","year":"2020","journal-title":"Cancer Treat. Res. Commun."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0041","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cei.12603","article-title":"Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes","volume":"180","author":"Fujisawa","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101309_bib0042","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-021-01388-5","article-title":"Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child","volume":"27","author":"Ogishi","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0043","first-page":"1","article-title":"Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency","volume":"221","author":"Johnson","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ctarc.2026.101309_bib0044","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ebiom.2016.05.003","article-title":"Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer","volume":"8","author":"Friedrich","year":"2016","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101309_bib0045","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/carcin\/bgt142","article-title":"Deficiency of caveolin-1 in Apc(min\/+) mice promotes colorectal tumorigenesis","volume":"34","author":"Friedrich","year":"2013","journal-title":"Carcinogenesis"},{"issue":"16","key":"10.1016\/j.ctarc.2026.101309_bib0046","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/MCB.01421-10","article-title":"The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor gamma through spatial relocalization at helix 7 of its ligand-binding domain","volume":"31","author":"Burgermeister","year":"2011","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0047","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/acer.13049","article-title":"Hepatic peroxisome proliferator-activated receptor gamma signaling contributes to alcohol-induced Hepatic steatosis and inflammation in mice","volume":"40","author":"Zhang","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101309_bib0048","doi-asserted-by":"crossref","first-page":"333","DOI":"10.34172\/bi.2022.24209","article-title":"Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models","volume":"13","author":"Tokhanbigli","year":"2023","journal-title":"Bioimpacts"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0049","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/0008-5472.CAN-17-3053","article-title":"Activation of peroxisome proliferator-activated receptors alpha and delta synergizes with inflammatory signals to enhance adoptive cell therapy","volume":"79","author":"Saibil","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0050","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1089\/jir.2014.0209","article-title":"The mechanism of interferon refractoriness during Hepatitis C Virus infection and its reversal with a peroxisome proliferator-activated receptor alpha agonist","volume":"35","author":"Read","year":"2015","journal-title":"J. Interferon. Cytokine Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101309_bib0051","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40659-018-0153-z","article-title":"Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARalpha)-deficient mice","volume":"51","author":"Hines","year":"2018","journal-title":"Biol. Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0052","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.1800224","article-title":"PPARgamma deficiency suppresses the release of IL-1beta and IL-1alpha in macrophages via a type 1 IFN-dependent mechanism","volume":"201","author":"Weber","year":"2018","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0053","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/ijms21072523","article-title":"Pioglitazone-mediated peroxisome proliferator-activated receptor gamma activation aggravates murine immune-mediated Hepatitis","volume":"21","author":"Schulte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101309_bib0054","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-020-00876-4","article-title":"How to select IgG subclasses in developing anti-tumor therapeutic antibodies","volume":"13","author":"Yu","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101309_bib0055","article-title":"Penpulimab, an fc-engineered IgG1 anti-PD-1 antibody, with improved efficacy and low incidence of immune-related adverse events","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0056","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0057","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri.2016.54","article-title":"Origins of the cytolytic synapse","volume":"16","author":"de la Roche","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101309_bib0058","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri2526","article-title":"The role of TNF superfamily members in T-cell function and diseases","volume":"9","author":"Croft","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101309_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3275","article-title":"Inhibitory effect and mechanism of Rosiglitazone on M1 type polarization of central microglia in intracerebral hemorrhage mice based on JNK\/STAT3 signaling pathway","volume":"13","author":"Chao","year":"2023","journal-title":"Brain Behav."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/2326-6066.CIR-21-0652","article-title":"High mobility group protein B1 decreases surface localization of PD-1 to augment T-cell activation","volume":"10","author":"Gao","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101309_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213375","article-title":"A CD64\/FcgammaRI-mediated mechanism hijacks PD-1 from PD-L1\/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells","volume":"14","author":"Joo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101309_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175749","article-title":"PPARgamma agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation","volume":"950","author":"Jia","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"31","key":"10.1016\/j.ctarc.2026.101309_bib0063","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1038\/s41388-021-01896-1","article-title":"Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer","volume":"40","author":"Qiu","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI160456","article-title":"PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination","volume":"133","author":"Yu","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"49","key":"10.1016\/j.ctarc.2026.101309_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abc2728","article-title":"Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding","volume":"5","author":"Andrews","year":"2020","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0066","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0067","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-gamma: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"27","key":"10.1016\/j.ctarc.2026.101309_bib0068","doi-asserted-by":"crossref","first-page":"25378","DOI":"10.1074\/jbc.M011363200","article-title":"Cytokine-independent Jak3 activation upon T cell receptor (TCR) stimulation through direct association of Jak3 and the TCR complex","volume":"276","author":"Tomita","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6702","key":"10.1016\/j.ctarc.2026.101309_bib0069","article-title":"Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients","volume":"384","author":"Mathew","year":"2024","journal-title":"Science (1979)"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101309_bib0070","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-19-1409","article-title":"Overcoming genetically based resistance mechanisms to PD-1 blockade","volume":"10","author":"Torrejon","year":"2020","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101309_bib0071","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101309_bib0072","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","article-title":"Regulatory mechanisms in T cell receptor signalling","volume":"18","author":"Gaud","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101309_bib0073","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.13313","article-title":"ITAM-based receptors in natural killer cells","volume":"323","author":"Aguilar","year":"2024","journal-title":"Immunol. Rev."},{"issue":"7775","key":"10.1016\/j.ctarc.2026.101309_bib0074","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41586-019-1537-0","article-title":"Structural basis of assembly of the human T cell receptor-CD3 complex","volume":"573","author":"Dong","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1074-7613(00)80057-6","article-title":"Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand","volume":"10","author":"Li","year":"1999","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101309_bib0076","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41589-019-0345-z","article-title":"Extracellular phosphorylation drives the formation of neuronal circuitry","volume":"15","author":"Harada","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ctarc.2026.101309_bib0077","article-title":"VLK drives extracellular phosphorylation of EphB2 to govern the EphB2-NMDAR interaction and injury-induced pain","author":"Srikanth","year":"2024","journal-title":"bioRxiv [Preprint]"},{"issue":"41","key":"10.1016\/j.ctarc.2026.101309_bib0078","doi-asserted-by":"crossref","first-page":"25677","DOI":"10.1074\/jbc.271.41.25677","article-title":"Phosphorylation of extracellular domains of T-lymphocyte surface proteins. Constitutive serine and threonine phosphorylation of the T cell antigen receptor ectodomains","volume":"271","author":"Apasov","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101309_bib0079","first-page":"31","article-title":"Genetically engineered nanomodulators elicit potent immunity against cancer stem cells by checkpoint blockade and hypoxia relief","volume":"38","author":"Pan","year":"2024","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101309_bib0080","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.matt.2022.02.015","article-title":"Nanomaterial-mediated ablation therapy for cancer stem cells","volume":"5","author":"Pan","year":"2022","journal-title":"Matter"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101309_bib0081","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400068","article-title":"Genetically engineered cytomembrane nanovaccines for cancer immunotherapy","volume":"13","author":"Pan","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101309_bib0082","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/gast.2002.34786","article-title":"Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice","volume":"123","author":"Janssen","year":"2002","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101309_bib0083","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.trecan.2019.09.004","article-title":"Serrated colorectal cancer: the road less travelled?","volume":"5","author":"Nakanishi","year":"2019","journal-title":"Trends. Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101309_bib0084","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000424","article-title":"The impact of KRAS mutation in patients with sporadic nonampullary duodenal epithelial tumors","volume":"12","author":"Kinugasa","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101309_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41389-020-0238-8","article-title":"Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma","volume":"9","author":"Weidner","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ctarc.2026.101309_bib0086","series-title":"Rosiglitazone","author":"Quintanilla Rodriguez","year":"2026"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101309_bib0087","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101309_bib0088","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.trecan.2025.04.010","article-title":"Repurposing glucose-lowering drugs for cancer therapy","volume":"11","author":"Luconi","year":"2025","journal-title":"Trends. Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:13Z","timestamp":1790913433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":88,"alternative-id":["S2468294226002200"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101309","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3 activation sensitizes MSS gastrointestinal cancer cells to PD1 blockage","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101309"}}